Related Experiment Videos
Prospective, randomized, controlled evaluation of a gentamicin loading dose in neonates
W Semchuk1, Y M Shevchuk, K Sankaran
1College of Pharmacy, Royal University Hospital, University of Saskatchewan, Saskatoon, Canada.
Biology of the Neonate
|January 1, 1995
Summary
A 4-mg/kg loading dose (LD) of gentamicin effectively achieved therapeutic peak serum concentrations in critically ill neonates, especially premature infants. This approach minimizes dosing intervals without increasing toxicity risk.
Area of Science:
- Neonatal pharmacology
- Antibiotic dosing strategies
Background:
- Gentamicin is crucial for treating neonatal infections.
- Standard gentamicin dosing may delay therapeutic concentrations in critically ill neonates.
Purpose of the Study:
- To compare a 4-mg/kg gentamicin loading dose (LD) versus standard regimens.
- To evaluate time to therapeutic peak serum concentration and toxicity risk.
Main Methods:
- Prospective, randomized, controlled trial in critically ill neonates.
- Comparison of 4-mg/kg LD versus 2.5 mg/kg standard doses.
- Analysis of peak serum concentrations and toxicity indicators.
Main Results:
- 13/13 neonates in the LD group achieved therapeutic peaks vs. 5/13 in the control group (p=0.012).
- No significant difference in toxic serum concentrations between groups.
- Neonates with gestational age ≤34 weeks showed lower initial peaks with standard dosing.
Conclusions:
- A 4-mg/kg gentamicin LD is effective for achieving therapeutic peaks in neonates, particularly those ≤34 weeks gestational age.
- Conventional dosing suffices for infants >34 weeks GA.
- Adjusting intervals based on creatinine minimizes toxicity risk.